RY 169.88 -1.0542% SHOP 144.59 -0.959% TD 77.85 -0.1667% ENB 59.62 -0.5505% BN 78.53 -0.971% TRI 223.92 -0.2495% CNQ 47.03 -0.0213% CP 102.49 -0.5627% CNR 147.77 -0.8787% BMO 131.32 -0.0685% BNS 78.4 0.0255% CSU 4463.7002 0.6222% CM 90.42 0.6344% MFC 44.91 -1.3184% ATD 77.0 -0.7604% NGT 60.01 -0.4149% TRP 68.0 -2.2989% SU 56.965 -0.4282% WCN 260.14 -0.653% L 176.45 0.7135%
Last update at 2024-11-20T19:29:00Z
Investing in Metro (TSE:MRU) five years ago would have delivered you a 60% gain
Sat 07 Sep 24, 12:21 PMMetro Inc. (TSE:MRU) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
Sat 17 Aug 24, 01:05 PMMETRO REPORTS 2024 THIRD QUARTER RESULTS
Wed 14 Aug 24, 11:00 AMEstimating The Intrinsic Value Of Metro Inc. (TSE:MRU)
Tue 13 Aug 24, 02:49 PM/R E P E A T -- METRO Inc. to Release 2024 Third Quarter Results/
Tue 13 Aug 24, 11:00 AMMETRO Inc. to Release 2024 Third Quarter Results
Wed 17 Jul 24, 11:00 AMMetro (TSE:MRU) Is Increasing Its Dividend To CA$0.335
Sun 04 Feb 24, 01:38 PMGrocery CEO Pushes Back Against Canada Minister’s Food-Price Criticisms
Tue 30 Jan 24, 07:36 PMBreakdown | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
Income before tax | 1153.60M | 1120.70M | 1084.30M | 969.20M | 2076.70M |
Minority interest | -3.40000M | -2.70000M | 13.20M | 13.40M | 52.50M |
Net income | 846.10M | 823.00M | 795.20M | 711.60M | 1716.50M |
Selling general administrative | 1389.50M | 1389.50M | 1348.00M | 1495.60M | 1338.70M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 3783.30M | 3654.80M | 3581.80M | 3328.70M | 2826.90M |
Reconciled depreciation | 503.30M | 478.30M | 462.50M | 286.40M | 233.50M |
Ebit | 1331.20M | 1266.50M | 1237.20M | 1069.80M | 2181.20M |
Ebitda | 1834.50M | 1744.80M | 1699.70M | 1356.20M | 2414.70M |
Depreciation and amortization | 503.30M | 478.30M | 462.50M | 286.40M | 233.50M |
Non operating income net other | - | - | - | - | - |
Operating income | 1331.20M | 1266.50M | 1237.20M | 1069.80M | 820.40M |
Other operating expenses | 17572.90M | 17028.80M | 16768.90M | 15702.40M | 13563.00M |
Interest expense | 132.80M | 145.80M | 145.40M | 108.50M | 106.50M |
Tax provision | 304.10M | 295.00M | 287.90M | 254.80M | 358.20M |
Interest income | 117.60M | 128.90M | 132.60M | 63.60M | 1302.60M |
Net interest income | -117.60000M | -133.50000M | -136.80000M | -103.80000M | -80.20000M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 304.10M | 295.00M | 287.90M | 254.80M | 358.20M |
Total revenue | 18888.90M | 18283.00M | 17997.50M | 16767.50M | 14383.40M |
Total operating expenses | 2467.30M | 2400.60M | 2353.20M | 2263.60M | 2006.50M |
Cost of revenue | 15105.60M | 14628.20M | 14415.70M | 13438.80M | 11556.50M |
Total other income expense net | -177.60000M | -145.80000M | -152.90000M | -100.60000M | 1256.30M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 849.50M | 825.70M | 796.40M | 714.40M | 1718.50M |
Net income applicable to common shares | 846.10M | 823.00M | 795.20M | 711.60M | 1716.50M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
Total assets | 13865.30M | 13401.30M | 13592.10M | 13423.90M | 11073.90M |
Intangible assets | 2733.00M | 2739.00M | 2854.70M | 2850.20M | 2889.00M |
Earning assets | - | - | - | - | - |
Other current assets | - | 54.10M | 46.60M | 45.00M | 33.20M |
Total liab | 7049.00M | 6782.90M | 7179.30M | 7268.50M | 5105.30M |
Total stockholder equity | 6801.20M | 6604.50M | 6399.90M | 6142.20M | 5955.20M |
Deferred long term liab | - | - | - | - | - |
Other current liab | - | 44.10M | 55.00M | 168.40M | 95.30M |
Common stock | - | 1649.30M | 1674.30M | 1713.80M | 1732.30M |
Capital stock | 1601.10M | 1649.30M | 1674.30M | 1713.80M | 1732.30M |
Retained earnings | 5195.60M | 4947.20M | 4721.90M | 4431.30M | 4228.30M |
Other liab | - | 1003.20M | 1005.40M | 985.00M | 986.60M |
Good will | 3307.40M | 3301.20M | 3301.20M | 3300.70M | 3306.50M |
Other assets | - | 725.00M | 774.90M | 761.20M | 132.30M |
Cash | 29.50M | 13.40M | 445.80M | 441.50M | 273.40M |
Cash and equivalents | - | 13.40M | 445.80M | 441.50M | 273.40M |
Total current liabilities | 1960.80M | 1952.50M | 2198.20M | 1860.10M | 1877.60M |
Current deferred revenue | - | 38.50M | 35.90M | 38.00M | 22.30M |
Net debt | 2636.10M | 4108.40M | 4118.20M | 4260.90M | 2394.60M |
Short term debt | - | 294.60M | 588.30M | 279.00M | 428.60M |
Short long term debt | 19.30M | 18.30M | 318.60M | 21.00M | 428.60M |
Short long term debt total | - | 4121.80M | 4564.00M | 4702.40M | 2668.00M |
Other stockholder equity | - | 7.10M | 3.70M | -2.90000M | -5.40000M |
Property plant equipment | - | 4452.80M | 4194.50M | 4011.30M | 2657.80M |
Total current assets | 2403.60M | 2183.30M | 2466.80M | 2500.50M | 2088.30M |
Long term investments | - | 9.40M | - | - | 0.00000M |
Net tangible assets | - | 564.30M | 244.00M | -8.70000M | -240.30000M |
Short term investments | - | - | - | - | - |
Net receivables | 728.30M | 784.70M | 805.40M | 745.80M | 655.70M |
Long term debt | 2646.30M | 2324.50M | 2318.20M | 2612.00M | 2211.70M |
Inventory | 1451.00M | 1331.10M | 1169.00M | 1268.20M | 1126.00M |
Accounts payable | 1619.40M | 1575.30M | 1546.50M | 1458.90M | 1331.40M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | 0.90M | - | -1641.50000M | -1574.20000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 1713.80M | 1732.30M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | -20.50000M | -25.10000M | -24.60000M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 85.30M | 670.80M | 717.80M | 717.70M | 129.50M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 11461.70M | 11218.00M | 11125.30M | 10923.40M | 8985.60M |
Capital lease obligations | 1658.70M | 1779.00M | 1927.20M | 2069.40M | 10.40M |
Long term debt total | - | 3827.20M | 3975.70M | 4423.40M | 2239.40M |
Breakdown | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
Investments | -477.80000M | -1.10000M | -444.10000M | -308.50000M | -1677.50000M |
Change to liabilities | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
Total cashflows from investing activities | -477.80000M | -471.60000M | -444.10000M | -308.50000M | -1677.50000M |
Net borrowings | -554.30000M | -263.30000M | -268.10000M | -7.40000M | 1172.60M |
Total cash from financing activities | -1416.00000M | -1107.40000M | -861.90000M | -332.70000M | 1005.10M |
Change to operating activities | -115.20000M | 162.20M | -34.50000M | -54.50000M | -54.30000M |
Net income | 1153.60M | 1120.70M | 1084.30M | 969.20M | 2076.70M |
Change in cash | -432.40000M | 4.30M | 168.10M | 46.50M | 78.00M |
Begin period cash flow | 445.80M | 441.50M | 273.40M | 226.90M | 148.90M |
End period cash flow | 13.40M | 445.80M | 441.50M | 273.40M | 226.90M |
Total cash from operating activities | 1461.40M | 1583.30M | 1474.10M | 687.70M | 750.40M |
Issuance of capital stock | 21.00M | 12.60M | 7.20M | 24.00M | 8.80M |
Depreciation | 503.30M | 478.30M | 462.50M | 286.40M | 233.50M |
Other cashflows from investing activities | 96.00M | 106.40M | 102.30M | 9.20M | 67.80M |
Dividends paid | 257.90M | 240.10M | 220.70M | 198.90M | 164.80M |
Change to inventory | - | - | - | - | - |
Change to account receivables | - | - | - | - | - |
Sale purchase of stock | -470.00000M | -456.30000M | -223.40000M | -151.50000M | -10.20000M |
Other cashflows from financing activities | 175.70M | -138.70000M | 256.60M | 47.60M | 2166.50M |
Change to netincome | 227.20M | 118.10M | 248.50M | -151.80000M | -1147.50000M |
Capital expenditures | 621.10M | 599.30M | 510.70M | 396.30M | 317.40M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -115.20000M | 162.20M | -34.50000M | -54.50000M | -54.30000M |
Stock based compensation | 8.60M | 10.60M | 9.50M | 8.60M | 9.10M |
Other non cash items | -88.90000M | -188.50000M | -47.70000M | -522.00000M | -1514.60000M |
Free cash flow | 840.30M | 984.00M | 963.40M | 291.40M | 433.00M |
Sector: Consumer Defensive Industry: Grocery Stores
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
MRU Metro Inc. |
0.96 1.11% | 87.24 | 21.07 | 18.18 | 0.90 | 2.79 | 1.10 | 11.85 |
L Loblaw Companies Limited |
1.25 0.71% | 176.45 | 28.18 | 19.72 | 0.94 | 5.14 | 1.22 | 11.01 |
WN George Weston Limited |
2.01 0.93% | 217.11 | 25.97 | 17.64 | 0.50 | 5.43 | 0.83 | 7.33 |
NWC North West Company Inc |
0.06 0.11% | 52.94 | 19.76 | 14.64 | 1.02 | 3.66 | 1.18 | 9.49 |
Metro Inc., through its subsidiaries, operates as a retailer, franchisor, distributor, and manufacturer in the food and pharmaceutical sectors in Canada. The company operates supermarkets, discount, neighborhood, and specialty stores that provide fresh and grocery products, baked goods, prepared food products, meats, dairy products, fruits and vegetables, frozen food products, bakery products, delicatessen items, and pastries. It also manufactures ready-to-eat meals, salads, dips, pastries, pies, breads, and cakes; generic drugs under Pro Doc trademark; and provides online grocery shopping services. In addition, the company offers its private label food products under Irresistibles, Selection, Our Harvest Best, Lucky Koi, Life Smart, Adonis, Phoenicia, and Premiere Moisson brands; and private label drug products comprising beauty and cosmetic products, over-the-counter medications, and personal care products, sold under the Personnelle brand name. It operates a network of food stores under various banners, including Metro, Metro Plus, Adonis, Super C, Marché Richelieu, Marché Ami, Première Moisson, Les 5 Saisons, and Food Basics, as well as drugstores primarily under the PJC Jean Coutu, PJC Santé, PJC Santé Beauté, Brunet, Brunet Plus, Brunet Clinique, Clini Plus, Metro Pharmacy, and Food Basics Pharmacy banners. The company was founded in 1947 and is headquartered in Montréal, Canada.
11011 Maurice-Duplessis Boulevard, Montréal, QC, Canada, H1C 1V6
Name | Title | Year Born |
---|---|---|
Mr. Eric Richer La Fleche | Pres, CEO & Non-Independent Director | 1962 |
Mr. Francois Thibault | Exec. VP, CFO & Treasurer | NA |
Mr. Marc Giroux | Exec. VP & COO ? Food | NA |
Mr. Carmen Fortino | Exec. VP of National Supply Chain & Procurement | 1959 |
Mr. Sam Bernier | VP of Technology Infrastructure | NA |
Mr. Frederic Legault | VP & Chief Information Officer | NA |
Mr. Simon Rivet | VP, Gen. Counsel & Corp. Sec. | NA |
Ms. Marie-Claude Bacon | VP of Public Affairs & Communications | NA |
Mr. Alain Tadros | VP of Marketing | NA |
Ms. Geneviève Bich | VP of HR | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.